Angélica María Zuluaga-Cabrera

Dr. Angélica María Zuluaga-Cabrera

Veterinary medicine and zootechnical faculty, Institución Universitaria Vision de las Americas, Medellín, Antioquia, Colombia
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2021 in Veterinary and Animal Science
Verified
Journal Article
Open access
Angélica María Zuluaga-CabreraAngélica María Zuluaga-Cabrera
Angélica María Zuluaga-Cabrera
MSMaria J. Casas Soto
Maria J. Casas Soto
JAJosé R. Martínez Aranzales
José R. Martínez Aranzales
NVNathalia M. Correa Valencia
Nathalia M. Correa Valencia
MGMaría P. Arias Gutiérrez
María P. Arias Gutiérrez
• The heart rate during the field exercise test increased according to the protocol used. • The blood lactate concentration values during the test were remarkably dispersed. • The mean blood lactate clearance percentage was 56.3 ± 16, similar in most animals. • The heart rate at which a blood lactate concentration of 4 mmol/L was reached was notably different among individuals.

14 October 2022 in Vaccines
Verified
Journal Article
Open access
PDF file
JGJuliana González
Juliana González
JFJorge Forero
Jorge Forero
Angélica María Zuluaga-CabreraAngélica María Zuluaga-Cabrera
Angélica María Zuluaga-Cabrera
Julián Ruiz-SáenzJulián Ruiz-Sáenz
Julián Ruiz-Sáenz
Equine influenza is a highly contagious disease caused by the H3N8 equine influenza virus (EIV), which is endemically distributed throughout the world. It infects equids, and interspecies transmission to dogs has been reported. The H3N8 Florida lineage, which is divided into clades 1 and 2, is the most representative lineage in the Americas. The EIV infects the respiratory system, affecting the ciliated epithelial cells and preventing the elimination of foreign bodies and substances. Certain factors related to the disease, such as an outdated vaccination plan, age, training, and close contact with other animals, favor the presentation of equine influenza. This review focuses on the molecular, pathophysiological, and epidemiological characteristics of EIV in the Americas to present updated information to achieve prevention and control of the virus. We also discuss the need for monitoring the disease, the use of vaccines, and the appropriate application of those biologicals, among other biosecurity measures that are important for the control of the virus.

9 April 2024 in Toxins
Verified
Journal Article
Open access
PDF file
SVSantiago Tabares Velez
Santiago Tabares Velez
LPLina María Preciado
Lina María Preciado
LMLeidy Johana Vargas Muñoz
Leidy Johana Vargas Muñoz
CBCarlos Alberto Madrid Bracamonte
Carlos Alberto Madrid Bracamonte
Angélica María Zuluaga-CabreraAngélica María Zuluaga-Cabrera
Angélica María Zuluaga-Cabrera
SGSebastian Estrada Gomez
Sebastian Estrada Gomez
In Colombia, Micrurus snakebites are classified as severe according to the national clinical care guidelines and must be treated with specific antivenoms. Unfortunately, these types of antivenoms are scarce in certain areas of the country and are currently reported as an unavailable vital medicine. To address this issue, La Universidad de Antioquia, through its spin-off Tech Life Saving, is leading a project to develop third-generation polyvalent freeze-dried antivenom. The goal is to ensure access to this therapy, especially in rural and dispersed areas. This project aims to evaluate the physicochemical and preclinical parameters (standard quality characteristics) of a lab-scale anti-elapid antivenom batch. The antivenom is challenged against the venoms of several Micrurus species, including M. mipartitus, M. dumerilii, M. ancoralis, M. dissoleucus, M. lemniscatus, M. medemi, M. spixii, M. surinamensis, and M. isozonus, following the standard quality characteristics set by the World Health Organization (WHO). The antivenom demonstrates an appearance consistent with standards, 100% solubility within 4 min and 25 s, an extractable volume of 10.39 mL, a pH of 6.04, an albumin concentration of 0.377 mg/mL (equivalent to 1.22% of total protein), and a protein concentration of 30.97 mg/mL. Importantly, it maintains full integrity of its F(ab′)2 fragments and exhibits purity over 98.5%. Furthermore, in mice toxicity evaluations, doses up to 15 mg/mouse show no toxic effects. The antivenom also demonstrates a significant recognition pattern against Micrurus venoms rich in phospholipase A2 (PLA2) content, as observed in M. dumerilii, M. dissoleucus, and M. isozonus. The effective dose 50 (ED50) indicates that a single vial (10 mL) can neutralize 2.33 mg of M. mipartitus venom and 3.99 mg of M. dumerilii venom. This new anti-elapid third-generation polyvalent and freeze-dried antivenom meets the physicochemical parameters set by the WHO and the regulators in Colombia. It demonstrates significant efficacy in neutralizing the venom of the most epidemiologically important Micrurus species in Colombia. Additionally, it recognizes seven other species of Micrurus venom with a higher affinity for venoms exhibiting PLA2 toxins. Fulfilling these parameters represents the first step toward proposing a new pharmacological alternative for treating snakebites in Colombia, particularly in dispersed rural areas, given that this antivenom is formulated as a freeze-dried product.

11 April 2022 in Revista Mexicana de Ciencias Pecuarias
Verified
Journal Article
Open access
PDF file
Angélica María Zuluaga-CabreraAngélica María Zuluaga-Cabrera
Angélica María Zuluaga-Cabrera
MSMaría José Casas Soto
María José Casas Soto
JAJosé Ramón Martínez Aranzales
José Ramón Martínez Aranzales
CVCastillo-Vanegas Viviana
Castillo-Vanegas Viviana
NVNathalia María del Pilar Correa Valencia
Nathalia María del Pilar Correa Valencia
MGMaría Patricia Arias Gutiérrez
María Patricia Arias Gutiérrez
The present study aimed to describe the hematological, biochemical, and endocrine parameters in acute response to increasing-intensity exercise in Colombian Paso horses (CPHs). A standardized field exercise test was carried out on 11 untrained adult CPHs of both sexes. The variables of interest were measured before and after the test (i.e. hematocrit, total plasma proteins, creatine kinase, creatinine, blood urea nitrogen —BUN, aspartate aminotransferase, gamma glutamyl transpeptidase, triglycerides, cholesterol, alkaline phosphatase, cortisol, insulin, blood sugar levels). Evidence of sympathetic-adrenergic response activation, described for other breeds and equestrian sports disciplines (i.e. hemoconcentration, negative change in plasma volume, slight increase in creatinine and BUN) was found. In addition, evidence of mobilization and use of energy sources such as glucose and triglycerides was found. In conclusion, the increasing-intensity exercise carried out during a standardized field test produced a negative change in plasma volume and the activation of the classic sympathetic-adrenergic response in CPHs.

1 December 2020 in Brazilian Journal of Veterinary Research and Animal Science
Verified
Journal Article
Open access
PDF file
Angélica María Zuluaga-CabreraAngélica María Zuluaga-Cabrera
Angélica María Zuluaga-Cabrera
NVNathalia María del Pilar Correa Valencia
Nathalia María del Pilar Correa Valencia
The body condition score (BCS) is insufficient in determining the amount of body fat in horses, thus defining obesity. Measurement of the subcutaneous fat thickness (SFT) by ultrasonography should be considered as an appropriate method in the definition of fat distribution at different body locations in horses. Therefore, this study aimed to 1) characterize the SFT in three different anatomical locations (i.e. neck, lumbar region, and gluteal region); 2) evaluate the relationship between BCS and SFT; 3) determine the influence of gender, weight, age, and gait on BCS and SFT measurements, and 4) explore the agreement between the morphometric measurements [i.e. body mass index (BMI), girth circumference: height at withers ratio (GC: HW), neck circumference: height at withers ratio (NC: HW)], and BCS and SFT in a population of Colombian Paso Horses (CPHs). The Henneke’s body condition scoring was applied to 69 adult CPHs,selected using a convenience sampling. Additionally, BMI, GC: HW, and NC: HW were calculated. Body fat percentage (BF%) was calculated by ultrasound measurement of the SFT in the neck, lumbar region, and gluteal region. The BF% in the CPHs was 6.4 ± 1.1. The GC: HW, NC: HW, and BMI were not predictors of the BF% or BCS, and neither gender nor gait was decisive in the definition of fattening in the study animals, although age and weight were determining variables. According to our results, ultrasound is an adequate tool to calculate the BF% of the CPHs. However, it must be accompanied by Henneke’s BCS assessment.

1 November 2024 in Journal of Veterinary Internal Medicine
Verified
Journal Article
Open access
SMShannon Massie
Shannon Massie
RLRenaud Léguillette
Renaud Léguillette
Warwick BaylyWarwick Bayly
Warwick Bayly
RSRay Sides
Ray Sides
Angélica María Zuluaga-CabreraAngélica María Zuluaga-Cabrera
Angélica María Zuluaga-Cabrera
Background: Workload associated with the high frequency Colombian Paso Fino gait has not been evaluated. Objectives: To determine the oxygen consumption (V̇O2), heart rate (HR), stride frequency: breathing ratio, and hematology associated with the Paso Fino gait, including whether exercise-induced pulmonary hemorrhage (EIPH) occurs. Animals: Eleven Paso Fino horses. Methods: Prospective cohort study. Horses performed a standardized Paso Fino gait test across a wooden sounding board, simulating competition. V̇O2 and ventilatory parameters (tidal volume [VT]; peak inspiratory and expiratory airflows [PkV̇I, PkV̇E]; respiratory rate [RR], minute ventilation [V̇E]) were measured using a portable ergospirometry facemask. Heart rate was measured using electrocardiograms. Post-exercise lactate, hematocrit, bicarbonate, pH, electrolytes, and biochemistry concentrations were measured. EIPH was assessed via tracheobronchoscopy. Four horses completed a secondary high-intensity gallop to elicit peak V̇O2 for comparative purposes. Results: Median [IQR] mean individual HR during the Paso Fino gait was 190 [178, 201] bpm. Relative V̇O2 measured 49.8 [48.4, 59.5] mL/(kg min; VT = 8.6 [8.0, 10.7] L; RR = 87.1 [75.4, 99.5] bpm; V̇E = 869 [740, 902] L/min; PkV̇I = 33.4 [32.7, 37.2] L/s; PkV̇E = 44.2 [40.3, 46.0] L/s). Horses took 2.8 [2.7, 2.9] strides/second and had a stride frequency: breathing ratio of 2.0 [1.8, 2.3]. Post-exercise blood lactate concentration and hematocrit measured 2.7 mmol/L and 50% respectively. Three horses showed endoscopic evidence of Grade-1 EIPH. The Paso Fino gait V̇O2 and HR equaled 79% V̇O2pk and 91% maximal HR, respectively, based on the high-intensity gallop. Conclusions and Clinical Importance: The Paso Fino gait represents submaximal exercise based on V̇O2 < V̇O2pk and blood lactate.